Highlights and Quick Summary
- Annual 3Y Operating CF Growth (per Share) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Operating CF Growth (per Share) for 2020 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Operating CF Growth (per Share) for 2018 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Operating CF Growth (per Share) of Atreca, Inc.
Most recent 3Y Operating CF Growth (per Share)of BCEL including historical data for past 10 years.Interactive Chart of 3Y Operating CF Growth (per Share) of Atreca, Inc.
Atreca, Inc. 3Y Operating CF Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology